Get our press releases & latest news first
Stay up to date. Find out about our latest research, products, exclusive partnerships and more.
We’re a leading bioscience company
With a global team and strategic collaborations, XPhyto is striving to make a real impact on medical innovation
XPhyto brings together cutting-edge companies and top researchers from around the world to innovate, accelerate and commercialize disruptive technology, from drug delivery formulations to diagnostics.
Innovative and Cutting-Edge Solutions
Our main areas of focus include:
Precision transdermal and oral drug formulations
Point-of-care (POC) diagnostics including rapid infectious disease screening
Production, formulation and validation of new active pharmaceutical ingredients (APIs)
Innovative drug delivery methods such as transdermal patches and oral dissolvable films for efficient and affordable treatment of a host of neurological diseases.
Development of effective, accessible rapid testing and biosensors for early detection and the potential for better treatment outcomes.
Innovation to Impact
Pandemic Management and Impacts on Mental Health & Addictions
Our research and innovation have the potential to impact lives around the world.
Learn more about how XPhyto products could change the lives of people suffering from conditions and how our new research may impact the state of our global community.
XPhyto signs Distribution Agreement for Czech Republic, rollout planned for Hungary, Slovakia, Ukraine and Russia
Jan 13, 2022
Vancouver, Canada, and Uttenweiler, Germany (January 13, 2022) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce...
Jan 10, 2022
Vancouver, Canada, and Uttenweiler, Germany (January 10, 2022) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce...